Global Biothrax (Anthrax Vaccine) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
LPI (LP Information)' newest research report, the “Biothrax (Anthrax Vaccine) Industry Forecast” looks at past sales and reviews total world Biothrax (Anthrax Vaccine) sales in 2022, providing a comprehensive analysis by region and market sector of projected Biothrax (Anthrax Vaccine) sales for 2023 through 2029. With Biothrax (Anthrax Vaccine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biothrax (Anthrax Vaccine) industry.
This Insight Report provides a comprehensive analysis of the global Biothrax (Anthrax Vaccine) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biothrax (Anthrax Vaccine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biothrax (Anthrax Vaccine) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biothrax (Anthrax Vaccine) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biothrax (Anthrax Vaccine).
The global Biothrax (Anthrax Vaccine) market size is projected to grow from US$ 640.8 million in 2022 to US$ 811 million in 2029; it is expected to grow at a CAGR of 811 from 2023 to 2029.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
This report presents a comprehensive overview, market shares, and growth opportunities of Biothrax (Anthrax Vaccine) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Biothrax (Anthrax Vaccine) market?
What factors are driving Biothrax (Anthrax Vaccine) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biothrax (Anthrax Vaccine) market opportunities vary by end market size?
How does Biothrax (Anthrax Vaccine) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
LPI (LP Information)' newest research report, the “Biothrax (Anthrax Vaccine) Industry Forecast” looks at past sales and reviews total world Biothrax (Anthrax Vaccine) sales in 2022, providing a comprehensive analysis by region and market sector of projected Biothrax (Anthrax Vaccine) sales for 2023 through 2029. With Biothrax (Anthrax Vaccine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biothrax (Anthrax Vaccine) industry.
This Insight Report provides a comprehensive analysis of the global Biothrax (Anthrax Vaccine) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biothrax (Anthrax Vaccine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biothrax (Anthrax Vaccine) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biothrax (Anthrax Vaccine) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biothrax (Anthrax Vaccine).
The global Biothrax (Anthrax Vaccine) market size is projected to grow from US$ 640.8 million in 2022 to US$ 811 million in 2029; it is expected to grow at a CAGR of 811 from 2023 to 2029.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
This report presents a comprehensive overview, market shares, and growth opportunities of Biothrax (Anthrax Vaccine) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Live Vaccines
- Cell Free PA Vaccines
- Human Use
- Animal Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merial
- Merck
- Zoetis
- Bayer Sanidad Animal
- Colorado Serum
- PharmAthene
- Tiankang
- Biog?nesis-Bago
- CAVAC
- Rosenbusch
- Agrovet
- Vecol
- CVCRI
- IVPM
- Prondil
- CDV
- Indian Immunologicals
- Botswana Vaccine Institute
- Ceva Sant? Animale
- Intervac
- JOVAC
What is the 10-year outlook for the global Biothrax (Anthrax Vaccine) market?
What factors are driving Biothrax (Anthrax Vaccine) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biothrax (Anthrax Vaccine) market opportunities vary by end market size?
How does Biothrax (Anthrax Vaccine) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Country/Region, 2018, 2022 & 2029
2.2 Biothrax (Anthrax Vaccine) Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell Free PA Vaccines
2.3 Biothrax (Anthrax Vaccine) Sales by Type
2.3.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
2.3.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Type (2018-2023)
2.4 Biothrax (Anthrax Vaccine) Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Biothrax (Anthrax Vaccine) Sales by Application
2.5.1 Global Biothrax (Anthrax Vaccine) Sale Market Share by Application (2018-2023)
2.5.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biothrax (Anthrax Vaccine) Sale Price by Application (2018-2023)
3 GLOBAL BIOTHRAX (ANTHRAX VACCINE) BY COMPANY
3.1 Global Biothrax (Anthrax Vaccine) Breakdown Data by Company
3.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Company (2018-2023)
3.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2018-2023)
3.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Company (2018-2023)
3.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Company (2018-2023)
3.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2018-2023)
3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Company
3.4 Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biothrax (Anthrax Vaccine) Product Location Distribution
3.4.2 Players Biothrax (Anthrax Vaccine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOTHRAX (ANTHRAX VACCINE) BY GEOGRAPHIC REGION
4.1 World Historic Biothrax (Anthrax Vaccine) Market Size by Geographic Region (2018-2023)
4.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biothrax (Anthrax Vaccine) Market Size by Country/Region (2018-2023)
4.2.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biothrax (Anthrax Vaccine) Sales Growth
4.4 APAC Biothrax (Anthrax Vaccine) Sales Growth
4.5 Europe Biothrax (Anthrax Vaccine) Sales Growth
4.6 Middle East & Africa Biothrax (Anthrax Vaccine) Sales Growth
5 AMERICAS
5.1 Americas Biothrax (Anthrax Vaccine) Sales by Country
5.1.1 Americas Biothrax (Anthrax Vaccine) Sales by Country (2018-2023)
5.1.2 Americas Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023)
5.2 Americas Biothrax (Anthrax Vaccine) Sales by Type
5.3 Americas Biothrax (Anthrax Vaccine) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biothrax (Anthrax Vaccine) Sales by Region
6.1.1 APAC Biothrax (Anthrax Vaccine) Sales by Region (2018-2023)
6.1.2 APAC Biothrax (Anthrax Vaccine) Revenue by Region (2018-2023)
6.2 APAC Biothrax (Anthrax Vaccine) Sales by Type
6.3 APAC Biothrax (Anthrax Vaccine) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biothrax (Anthrax Vaccine) by Country
7.1.1 Europe Biothrax (Anthrax Vaccine) Sales by Country (2018-2023)
7.1.2 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023)
7.2 Europe Biothrax (Anthrax Vaccine) Sales by Type
7.3 Europe Biothrax (Anthrax Vaccine) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biothrax (Anthrax Vaccine) by Country
8.1.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023)
8.2 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type
8.3 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine)
10.3 Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
10.4 Industry Chain Structure of Biothrax (Anthrax Vaccine)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biothrax (Anthrax Vaccine) Distributors
11.3 Biothrax (Anthrax Vaccine) Customer
12 WORLD FORECAST REVIEW FOR BIOTHRAX (ANTHRAX VACCINE) BY GEOGRAPHIC REGION
12.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region
12.1.1 Global Biothrax (Anthrax Vaccine) Forecast by Region (2024-2029)
12.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biothrax (Anthrax Vaccine) Forecast by Type
12.7 Global Biothrax (Anthrax Vaccine) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merial
13.1.1 Merial Company Information
13.1.2 Merial Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merial Main Business Overview
13.1.5 Merial Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Bayer Sanidad Animal
13.4.1 Bayer Sanidad Animal Company Information
13.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Sanidad Animal Main Business Overview
13.4.5 Bayer Sanidad Animal Latest Developments
13.5 Colorado Serum
13.5.1 Colorado Serum Company Information
13.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Colorado Serum Main Business Overview
13.5.5 Colorado Serum Latest Developments
13.6 PharmAthene
13.6.1 PharmAthene Company Information
13.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 PharmAthene Main Business Overview
13.6.5 PharmAthene Latest Developments
13.7 Tiankang
13.7.1 Tiankang Company Information
13.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Tiankang Main Business Overview
13.7.5 Tiankang Latest Developments
13.8 Biog?nesis-Bago
13.8.1 Biog?nesis-Bago Company Information
13.8.2 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.8.3 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biog?nesis-Bago Main Business Overview
13.8.5 Biog?nesis-Bago Latest Developments
13.9 CAVAC
13.9.1 CAVAC Company Information
13.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 CAVAC Main Business Overview
13.9.5 CAVAC Latest Developments
13.10 Rosenbusch
13.10.1 Rosenbusch Company Information
13.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Rosenbusch Main Business Overview
13.10.5 Rosenbusch Latest Developments
13.11 Agrovet
13.11.1 Agrovet Company Information
13.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Agrovet Main Business Overview
13.11.5 Agrovet Latest Developments
13.12 Vecol
13.12.1 Vecol Company Information
13.12.2 Vecol Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Vecol Main Business Overview
13.12.5 Vecol Latest Developments
13.13 CVCRI
13.13.1 CVCRI Company Information
13.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 CVCRI Main Business Overview
13.13.5 CVCRI Latest Developments
13.14 IVPM
13.14.1 IVPM Company Information
13.14.2 IVPM Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 IVPM Main Business Overview
13.14.5 IVPM Latest Developments
13.15 Prondil
13.15.1 Prondil Company Information
13.15.2 Prondil Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Prondil Main Business Overview
13.15.5 Prondil Latest Developments
13.16 CDV
13.16.1 CDV Company Information
13.16.2 CDV Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 CDV Main Business Overview
13.16.5 CDV Latest Developments
13.17 Indian Immunologicals
13.17.1 Indian Immunologicals Company Information
13.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Indian Immunologicals Main Business Overview
13.17.5 Indian Immunologicals Latest Developments
13.18 Botswana Vaccine Institute
13.18.1 Botswana Vaccine Institute Company Information
13.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Botswana Vaccine Institute Main Business Overview
13.18.5 Botswana Vaccine Institute Latest Developments
13.19 Ceva Sant? Animale
13.19.1 Ceva Sant? Animale Company Information
13.19.2 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.19.3 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Ceva Sant? Animale Main Business Overview
13.19.5 Ceva Sant? Animale Latest Developments
13.20 Intervac
13.20.1 Intervac Company Information
13.20.2 Intervac Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Intervac Main Business Overview
13.20.5 Intervac Latest Developments
13.21 JOVAC
13.21.1 JOVAC Company Information
13.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 JOVAC Main Business Overview
13.21.5 JOVAC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Country/Region, 2018, 2022 & 2029
2.2 Biothrax (Anthrax Vaccine) Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell Free PA Vaccines
2.3 Biothrax (Anthrax Vaccine) Sales by Type
2.3.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
2.3.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Type (2018-2023)
2.4 Biothrax (Anthrax Vaccine) Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Biothrax (Anthrax Vaccine) Sales by Application
2.5.1 Global Biothrax (Anthrax Vaccine) Sale Market Share by Application (2018-2023)
2.5.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biothrax (Anthrax Vaccine) Sale Price by Application (2018-2023)
3 GLOBAL BIOTHRAX (ANTHRAX VACCINE) BY COMPANY
3.1 Global Biothrax (Anthrax Vaccine) Breakdown Data by Company
3.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Company (2018-2023)
3.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2018-2023)
3.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Company (2018-2023)
3.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Company (2018-2023)
3.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2018-2023)
3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Company
3.4 Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biothrax (Anthrax Vaccine) Product Location Distribution
3.4.2 Players Biothrax (Anthrax Vaccine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOTHRAX (ANTHRAX VACCINE) BY GEOGRAPHIC REGION
4.1 World Historic Biothrax (Anthrax Vaccine) Market Size by Geographic Region (2018-2023)
4.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biothrax (Anthrax Vaccine) Market Size by Country/Region (2018-2023)
4.2.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biothrax (Anthrax Vaccine) Sales Growth
4.4 APAC Biothrax (Anthrax Vaccine) Sales Growth
4.5 Europe Biothrax (Anthrax Vaccine) Sales Growth
4.6 Middle East & Africa Biothrax (Anthrax Vaccine) Sales Growth
5 AMERICAS
5.1 Americas Biothrax (Anthrax Vaccine) Sales by Country
5.1.1 Americas Biothrax (Anthrax Vaccine) Sales by Country (2018-2023)
5.1.2 Americas Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023)
5.2 Americas Biothrax (Anthrax Vaccine) Sales by Type
5.3 Americas Biothrax (Anthrax Vaccine) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biothrax (Anthrax Vaccine) Sales by Region
6.1.1 APAC Biothrax (Anthrax Vaccine) Sales by Region (2018-2023)
6.1.2 APAC Biothrax (Anthrax Vaccine) Revenue by Region (2018-2023)
6.2 APAC Biothrax (Anthrax Vaccine) Sales by Type
6.3 APAC Biothrax (Anthrax Vaccine) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biothrax (Anthrax Vaccine) by Country
7.1.1 Europe Biothrax (Anthrax Vaccine) Sales by Country (2018-2023)
7.1.2 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023)
7.2 Europe Biothrax (Anthrax Vaccine) Sales by Type
7.3 Europe Biothrax (Anthrax Vaccine) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biothrax (Anthrax Vaccine) by Country
8.1.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023)
8.2 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type
8.3 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine)
10.3 Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
10.4 Industry Chain Structure of Biothrax (Anthrax Vaccine)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biothrax (Anthrax Vaccine) Distributors
11.3 Biothrax (Anthrax Vaccine) Customer
12 WORLD FORECAST REVIEW FOR BIOTHRAX (ANTHRAX VACCINE) BY GEOGRAPHIC REGION
12.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region
12.1.1 Global Biothrax (Anthrax Vaccine) Forecast by Region (2024-2029)
12.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biothrax (Anthrax Vaccine) Forecast by Type
12.7 Global Biothrax (Anthrax Vaccine) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merial
13.1.1 Merial Company Information
13.1.2 Merial Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merial Main Business Overview
13.1.5 Merial Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Bayer Sanidad Animal
13.4.1 Bayer Sanidad Animal Company Information
13.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Sanidad Animal Main Business Overview
13.4.5 Bayer Sanidad Animal Latest Developments
13.5 Colorado Serum
13.5.1 Colorado Serum Company Information
13.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Colorado Serum Main Business Overview
13.5.5 Colorado Serum Latest Developments
13.6 PharmAthene
13.6.1 PharmAthene Company Information
13.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 PharmAthene Main Business Overview
13.6.5 PharmAthene Latest Developments
13.7 Tiankang
13.7.1 Tiankang Company Information
13.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Tiankang Main Business Overview
13.7.5 Tiankang Latest Developments
13.8 Biog?nesis-Bago
13.8.1 Biog?nesis-Bago Company Information
13.8.2 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.8.3 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biog?nesis-Bago Main Business Overview
13.8.5 Biog?nesis-Bago Latest Developments
13.9 CAVAC
13.9.1 CAVAC Company Information
13.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 CAVAC Main Business Overview
13.9.5 CAVAC Latest Developments
13.10 Rosenbusch
13.10.1 Rosenbusch Company Information
13.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Rosenbusch Main Business Overview
13.10.5 Rosenbusch Latest Developments
13.11 Agrovet
13.11.1 Agrovet Company Information
13.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Agrovet Main Business Overview
13.11.5 Agrovet Latest Developments
13.12 Vecol
13.12.1 Vecol Company Information
13.12.2 Vecol Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Vecol Main Business Overview
13.12.5 Vecol Latest Developments
13.13 CVCRI
13.13.1 CVCRI Company Information
13.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 CVCRI Main Business Overview
13.13.5 CVCRI Latest Developments
13.14 IVPM
13.14.1 IVPM Company Information
13.14.2 IVPM Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 IVPM Main Business Overview
13.14.5 IVPM Latest Developments
13.15 Prondil
13.15.1 Prondil Company Information
13.15.2 Prondil Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Prondil Main Business Overview
13.15.5 Prondil Latest Developments
13.16 CDV
13.16.1 CDV Company Information
13.16.2 CDV Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 CDV Main Business Overview
13.16.5 CDV Latest Developments
13.17 Indian Immunologicals
13.17.1 Indian Immunologicals Company Information
13.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Indian Immunologicals Main Business Overview
13.17.5 Indian Immunologicals Latest Developments
13.18 Botswana Vaccine Institute
13.18.1 Botswana Vaccine Institute Company Information
13.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Botswana Vaccine Institute Main Business Overview
13.18.5 Botswana Vaccine Institute Latest Developments
13.19 Ceva Sant? Animale
13.19.1 Ceva Sant? Animale Company Information
13.19.2 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.19.3 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Ceva Sant? Animale Main Business Overview
13.19.5 Ceva Sant? Animale Latest Developments
13.20 Intervac
13.20.1 Intervac Company Information
13.20.2 Intervac Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Intervac Main Business Overview
13.20.5 Intervac Latest Developments
13.21 JOVAC
13.21.1 JOVAC Company Information
13.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
13.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 JOVAC Main Business Overview
13.21.5 JOVAC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Cell Free PA Vaccines
Table 5. Global Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 6. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2023)
Table 9. Global Biothrax (Anthrax Vaccine) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Table 12. Global Biothrax (Anthrax Vaccine) Revenue by Application (2018-2023)
Table 13. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2023)
Table 14. Global Biothrax (Anthrax Vaccine) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Biothrax (Anthrax Vaccine) Sales by Company (2018-2023) & (K Units)
Table 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2018-2023)
Table 17. Global Biothrax (Anthrax Vaccine) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2018-2023)
Table 19. Global Biothrax (Anthrax Vaccine) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution and Sales Area
Table 21. Players Biothrax (Anthrax Vaccine) Products Offered
Table 22. Biothrax (Anthrax Vaccine) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biothrax (Anthrax Vaccine) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Biothrax (Anthrax Vaccine) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Biothrax (Anthrax Vaccine) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Biothrax (Anthrax Vaccine) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Biothrax (Anthrax Vaccine) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Biothrax (Anthrax Vaccine) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Biothrax (Anthrax Vaccine) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country (2018-2023)
Table 35. Americas Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2018-2023)
Table 37. Americas Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Biothrax (Anthrax Vaccine) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region (2018-2023)
Table 41. APAC Biothrax (Anthrax Vaccine) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2018-2023)
Table 43. APAC Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Biothrax (Anthrax Vaccine) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2018-2023)
Table 47. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2018-2023)
Table 49. Europe Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Biothrax (Anthrax Vaccine)
Table 58. Key Market Challenges & Risks of Biothrax (Anthrax Vaccine)
Table 59. Key Industry Trends of Biothrax (Anthrax Vaccine)
Table 60. Biothrax (Anthrax Vaccine) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Biothrax (Anthrax Vaccine) Distributors List
Table 63. Biothrax (Anthrax Vaccine) Customer List
Table 64. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Biothrax (Anthrax Vaccine) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Biothrax (Anthrax Vaccine) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merial Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 79. Merial Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 80. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merial Main Business
Table 82. Merial Latest Developments
Table 83. Merck Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 85. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Zoetis Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoetis Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 90. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Zoetis Main Business
Table 92. Zoetis Latest Developments
Table 93. Bayer Sanidad Animal Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 95. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Bayer Sanidad Animal Main Business
Table 97. Bayer Sanidad Animal Latest Developments
Table 98. Colorado Serum Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 99. Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 100. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Colorado Serum Main Business
Table 102. Colorado Serum Latest Developments
Table 103. PharmAthene Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 104. PharmAthene Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 105. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. PharmAthene Main Business
Table 107. PharmAthene Latest Developments
Table 108. Tiankang Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 109. Tiankang Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 110. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Tiankang Main Business
Table 112. Tiankang Latest Developments
Table 113. Biog?nesis-Bago Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 114. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 115. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Biog?nesis-Bago Main Business
Table 117. Biog?nesis-Bago Latest Developments
Table 118. CAVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 119. CAVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 120. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. CAVAC Main Business
Table 122. CAVAC Latest Developments
Table 123. Rosenbusch Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 124. Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 125. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Rosenbusch Main Business
Table 127. Rosenbusch Latest Developments
Table 128. Agrovet Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 129. Agrovet Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 130. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Agrovet Main Business
Table 132. Agrovet Latest Developments
Table 133. Vecol Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 134. Vecol Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 135. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Vecol Main Business
Table 137. Vecol Latest Developments
Table 138. CVCRI Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 139. CVCRI Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 140. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. CVCRI Main Business
Table 142. CVCRI Latest Developments
Table 143. IVPM Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 144. IVPM Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 145. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. IVPM Main Business
Table 147. IVPM Latest Developments
Table 148. Prondil Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 149. Prondil Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 150. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Prondil Main Business
Table 152. Prondil Latest Developments
Table 153. CDV Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 154. CDV Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 155. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. CDV Main Business
Table 157. CDV Latest Developments
Table 158. Indian Immunologicals Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 159. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 160. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Indian Immunologicals Main Business
Table 162. Indian Immunologicals Latest Developments
Table 163. Botswana Vaccine Institute Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 164. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 165. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Botswana Vaccine Institute Main Business
Table 167. Botswana Vaccine Institute Latest Developments
Table 168. Ceva Sant? Animale Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 169. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 170. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Ceva Sant? Animale Main Business
Table 172. Ceva Sant? Animale Latest Developments
Table 173. Intervac Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 174. Intervac Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 175. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Intervac Main Business
Table 177. Intervac Latest Developments
Table 178. JOVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 179. JOVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 180. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. JOVAC Main Business
Table 182. JOVAC Latest Developments
Table 1. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Cell Free PA Vaccines
Table 5. Global Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 6. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2023)
Table 9. Global Biothrax (Anthrax Vaccine) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Table 12. Global Biothrax (Anthrax Vaccine) Revenue by Application (2018-2023)
Table 13. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2023)
Table 14. Global Biothrax (Anthrax Vaccine) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Biothrax (Anthrax Vaccine) Sales by Company (2018-2023) & (K Units)
Table 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2018-2023)
Table 17. Global Biothrax (Anthrax Vaccine) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2018-2023)
Table 19. Global Biothrax (Anthrax Vaccine) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution and Sales Area
Table 21. Players Biothrax (Anthrax Vaccine) Products Offered
Table 22. Biothrax (Anthrax Vaccine) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biothrax (Anthrax Vaccine) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Biothrax (Anthrax Vaccine) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Biothrax (Anthrax Vaccine) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Biothrax (Anthrax Vaccine) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Biothrax (Anthrax Vaccine) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Biothrax (Anthrax Vaccine) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Biothrax (Anthrax Vaccine) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country (2018-2023)
Table 35. Americas Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2018-2023)
Table 37. Americas Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Biothrax (Anthrax Vaccine) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region (2018-2023)
Table 41. APAC Biothrax (Anthrax Vaccine) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2018-2023)
Table 43. APAC Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Biothrax (Anthrax Vaccine) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2018-2023)
Table 47. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2018-2023)
Table 49. Europe Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Biothrax (Anthrax Vaccine)
Table 58. Key Market Challenges & Risks of Biothrax (Anthrax Vaccine)
Table 59. Key Industry Trends of Biothrax (Anthrax Vaccine)
Table 60. Biothrax (Anthrax Vaccine) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Biothrax (Anthrax Vaccine) Distributors List
Table 63. Biothrax (Anthrax Vaccine) Customer List
Table 64. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Biothrax (Anthrax Vaccine) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Biothrax (Anthrax Vaccine) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merial Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 79. Merial Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 80. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merial Main Business
Table 82. Merial Latest Developments
Table 83. Merck Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 85. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Zoetis Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoetis Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 90. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Zoetis Main Business
Table 92. Zoetis Latest Developments
Table 93. Bayer Sanidad Animal Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 95. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Bayer Sanidad Animal Main Business
Table 97. Bayer Sanidad Animal Latest Developments
Table 98. Colorado Serum Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 99. Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 100. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Colorado Serum Main Business
Table 102. Colorado Serum Latest Developments
Table 103. PharmAthene Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 104. PharmAthene Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 105. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. PharmAthene Main Business
Table 107. PharmAthene Latest Developments
Table 108. Tiankang Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 109. Tiankang Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 110. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Tiankang Main Business
Table 112. Tiankang Latest Developments
Table 113. Biog?nesis-Bago Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 114. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 115. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Biog?nesis-Bago Main Business
Table 117. Biog?nesis-Bago Latest Developments
Table 118. CAVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 119. CAVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 120. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. CAVAC Main Business
Table 122. CAVAC Latest Developments
Table 123. Rosenbusch Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 124. Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 125. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Rosenbusch Main Business
Table 127. Rosenbusch Latest Developments
Table 128. Agrovet Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 129. Agrovet Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 130. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Agrovet Main Business
Table 132. Agrovet Latest Developments
Table 133. Vecol Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 134. Vecol Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 135. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Vecol Main Business
Table 137. Vecol Latest Developments
Table 138. CVCRI Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 139. CVCRI Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 140. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. CVCRI Main Business
Table 142. CVCRI Latest Developments
Table 143. IVPM Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 144. IVPM Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 145. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. IVPM Main Business
Table 147. IVPM Latest Developments
Table 148. Prondil Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 149. Prondil Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 150. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Prondil Main Business
Table 152. Prondil Latest Developments
Table 153. CDV Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 154. CDV Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 155. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. CDV Main Business
Table 157. CDV Latest Developments
Table 158. Indian Immunologicals Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 159. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 160. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Indian Immunologicals Main Business
Table 162. Indian Immunologicals Latest Developments
Table 163. Botswana Vaccine Institute Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 164. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 165. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Botswana Vaccine Institute Main Business
Table 167. Botswana Vaccine Institute Latest Developments
Table 168. Ceva Sant? Animale Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 169. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 170. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Ceva Sant? Animale Main Business
Table 172. Ceva Sant? Animale Latest Developments
Table 173. Intervac Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 174. Intervac Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 175. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Intervac Main Business
Table 177. Intervac Latest Developments
Table 178. JOVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 179. JOVAC Biothrax (Anthrax Vaccine) Product Portfolios and Specifications
Table 180. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. JOVAC Main Business
Table 182. JOVAC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biothrax (Anthrax Vaccine)
Figure 2. Biothrax (Anthrax Vaccine) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biothrax (Anthrax Vaccine) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Biothrax (Anthrax Vaccine) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biothrax (Anthrax Vaccine) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Cell Free PA Vaccines
Figure 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type in 2022
Figure 12. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2023)
Figure 13. Biothrax (Anthrax Vaccine) Consumed in Human Use
Figure 14. Global Biothrax (Anthrax Vaccine) Market: Human Use (2018-2023) & (K Units)
Figure 15. Biothrax (Anthrax Vaccine) Consumed in Animal Use
Figure 16. Global Biothrax (Anthrax Vaccine) Market: Animal Use (2018-2023) & (K Units)
Figure 17. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2022)
Figure 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application in 2022
Figure 19. Biothrax (Anthrax Vaccine) Sales Market by Company in 2022 (K Units)
Figure 20. Global Biothrax (Anthrax Vaccine) Sales Market Share by Company in 2022
Figure 21. Biothrax (Anthrax Vaccine) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company in 2022
Figure 23. Global Biothrax (Anthrax Vaccine) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 26. Americas Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 28. APAC Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 30. Europe Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2022
Figure 34. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2022
Figure 35. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 36. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 37. United States Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2022
Figure 42. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Regions in 2022
Figure 43. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 44. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 45. China Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2022
Figure 53. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2022
Figure 54. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 55. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 56. Germany Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine) in 2022
Figure 71. Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
Figure 72. Industry Chain Structure of Biothrax (Anthrax Vaccine)
Figure 73. Channels of Distribution
Figure 74. Global Biothrax (Anthrax Vaccine) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Biothrax (Anthrax Vaccine)
Figure 2. Biothrax (Anthrax Vaccine) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biothrax (Anthrax Vaccine) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Biothrax (Anthrax Vaccine) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biothrax (Anthrax Vaccine) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Cell Free PA Vaccines
Figure 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type in 2022
Figure 12. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2023)
Figure 13. Biothrax (Anthrax Vaccine) Consumed in Human Use
Figure 14. Global Biothrax (Anthrax Vaccine) Market: Human Use (2018-2023) & (K Units)
Figure 15. Biothrax (Anthrax Vaccine) Consumed in Animal Use
Figure 16. Global Biothrax (Anthrax Vaccine) Market: Animal Use (2018-2023) & (K Units)
Figure 17. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2022)
Figure 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application in 2022
Figure 19. Biothrax (Anthrax Vaccine) Sales Market by Company in 2022 (K Units)
Figure 20. Global Biothrax (Anthrax Vaccine) Sales Market Share by Company in 2022
Figure 21. Biothrax (Anthrax Vaccine) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company in 2022
Figure 23. Global Biothrax (Anthrax Vaccine) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 26. Americas Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 28. APAC Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 30. Europe Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Biothrax (Anthrax Vaccine) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2022
Figure 34. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2022
Figure 35. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 36. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 37. United States Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2022
Figure 42. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Regions in 2022
Figure 43. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 44. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 45. China Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2022
Figure 53. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2022
Figure 54. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 55. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 56. Germany Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Biothrax (Anthrax Vaccine) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine) in 2022
Figure 71. Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
Figure 72. Industry Chain Structure of Biothrax (Anthrax Vaccine)
Figure 73. Channels of Distribution
Figure 74. Global Biothrax (Anthrax Vaccine) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Application (2024-2029)
